XNCR

Xencor, Inc.

35.75

USD

+1.70

+4.99%

Nov 06, 15:59 UTC -5

Closed

After-Market

35.97

+0.22

+0.61%

Xencor, Inc. (XNCR) Profile

Xencor, Inc. Profile

About

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

Info & Links

CEO

Bassil I. Dahiyat

Headquarters

465 NORTH HALSTEAD STREET, SUITE 200
PASADENA, CA 91107, UNITED STATES

Auditor

KPMG LLP

Share holders

163

Employees

260

Xencor, Inc. Statistics

Valuation Measures

Market Capitalization²

2.70B

Enterprise Value

2.64B

Enterprise Value/EBITDA(ttm)

-18.94

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

13.38

Price to Book(mrq)

4.79

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-58.79%

Profit Margin(ttm)

-721.70%

Return on Equity(ttm)

-21.28%

Return on Invested Capital(ttm)

-23.33%

Return on Assets(ttm)

-15.17%

Income Statement

Revenue(ttm)

200.49M

Revenue Per Share(ttm)

2.67

Gross Profit(ttm)

200.49M

EBITDA(ttm)³

-139.35M

Net Income Available to Common(ttm)

-117.86M

Diluted EPS(ttm)

-1.59

Share Statistics

Beta (5Y Monthly)

0.78

52-Week Change

157.19%

S&P 500 52-Week Change

14.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

75.04M

Dividend Yield

0.00%

Float⁴

71.23M

% Held by Insiders

5.08%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

405.08M

Total Cash Per Share(mrq)

5.40

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.54%

Quick Ratio(mrq)

6.39%

Book Value Per Share(mrq)

7.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.54

Free Cash Flow(ytd)

-123.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.